Aurobindo Pharma arm secures UK MHRA approval for bevacizumab biosimilar Bevqolva

On Friday (December 20), shares of Aurobindo Pharma Ltd ended at ₹1,240.70, down by ₹14.70, or 1.17% on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *